Oxford Biomedical Technologies is recruiting participants for a new clinical research study to determine the effectiveness of the Lifestyle Eating and Performance (LEAP) Program for people with irritable bowel syndrome (IBS).
The LEAP Program is a non-medication/drug dietary approach intended to manage the symptoms of IBS. The LEAP Program customizes an eating plan for each individual based on the results of a patented food sensitivity blood test (MRT). Prior research on the LEAP Program shows a reduction in many chronic symptoms, especially the digestive complaints associated with IBS.
If you have been diagnosed with IBS and are looking for an alternative approach to better reduce your symptoms, you may want to participate in this study. This research will assess the clinical benefits of the LEAP Program in people who currently suffer moderate to severe IBS symptoms and whose current or past treatment has been unsatisfactory. This study may play an essential role in advancing the clinical care for IBS individuals, leading to improvements in health, quality of life, and reduced healthcare costs.
Research activities include:
- Blood collection for MRT food sensitivity blood test
- Physical measurements (weight, BMI, etc.) at various intervals
- Assessment of symptoms and quality of life with written study questionnaires
- Dietary counseling sessions
- 6 in-person study visits and 1 virtual visit over 90 days
Study participants must reside in South Florida for the duration of the study. Participants will receive the following:
- A free MRT 170 item food sensitivity blood test ($695 value)
- 6 free sessions with a Registered Dietitian ($450 value)
- $50 for each study visit to the clinic (up to $300 for full participation in the study over 90 days)
"*" indicates required fields